A Phase II, Multicenter, Randomized, Observer-Blind, Controlled Study to Evaluate Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women

Trial Profile

A Phase II, Multicenter, Randomized, Observer-Blind, Controlled Study to Evaluate Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs Streptococcal B vaccine conjugate (Primary)
  • Indications Streptococcal infections
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline; Novartis Vaccines
  • Most Recent Events

    • 30 Mar 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 09 Nov 2015 Planned End Date changed from 1 Jun 2016 to 1 Apr 2016 as reported by ClinicalTrial.gov record.
    • 09 Nov 2015 Planned primary completion date changed from 1 Jun 2016 to 1 Feb 2016 as reported by ClinicalTrial.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top